Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Long-Term Investments: 2022-2024

Historic Long-Term Investments for Cellebrite DI (CLBT) over the last 3 years, with Dec 2024 value amounting to $36.6 million.

  • Cellebrite DI's Long-Term Investments rose 203.93% to $117.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.1 million, marking a year-over-year increase of 203.93%. This contributed to the annual value of $36.6 million for FY2024, which is 26.83% up from last year.
  • As of FY2024, Cellebrite DI's Long-Term Investments stood at $36.6 million, which was up 26.83% from $28.9 million recorded in FY2023.
  • Cellebrite DI's Long-Term Investments' 5-year high stood at $36.6 million during FY2024, with a 5-year trough of $22.1 million in FY2022.
  • Its 3-year average for Long-Term Investments is $29.2 million, with a median of $28.9 million in 2023.
  • Data for Cellebrite DI's Long-Term Investments shows a peak YoY skyrocketed of 30.44% (in 2023) over the last 5 years.
  • Cellebrite DI's Long-Term Investments (Yearly) stood at $22.1 million in 2022, then skyrocketed by 30.44% to $28.9 million in 2023, then climbed by 26.83% to $36.6 million in 2024.